- Home
- NVNI vs GNTA Comparison
NVNI vs GNTA Comparison
Compare NVNI & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- GNTA
- Stock Information
- Founded
- NVNI 2019
- GNTA 2014
- Country
- NVNI Brazil
- GNTA Italy
- Employees
- NVNI N/A
- GNTA N/A
- Industry
- NVNI
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVNI
- GNTA Health Care
- Exchange
- NVNI Nasdaq
- GNTA Nasdaq
- Market Cap
- NVNI 57.2M
- GNTA 62.9M
- IPO Year
- NVNI N/A
- GNTA 2021
- Fundamental
- Price
- NVNI $0.64
- GNTA $2.95
- Analyst Decision
- NVNI
- GNTA Strong Buy
- Analyst Count
- NVNI 0
- GNTA 1
- Target Price
- NVNI N/A
- GNTA $25.00
- AVG Volume (30 Days)
- NVNI 2.1M
- GNTA 16.8K
- Earning Date
- NVNI 09-30-2025
- GNTA 01-01-0001
- Dividend Yield
- NVNI N/A
- GNTA N/A
- EPS Growth
- NVNI N/A
- GNTA N/A
- EPS
- NVNI N/A
- GNTA N/A
- Revenue
- NVNI $31,250,627.00
- GNTA N/A
- Revenue This Year
- NVNI $12.05
- GNTA N/A
- Revenue Next Year
- NVNI $15.02
- GNTA N/A
- P/E Ratio
- NVNI N/A
- GNTA N/A
- Revenue Growth
- NVNI 1491.58
- GNTA N/A
- 52 Week Low
- NVNI $0.14
- GNTA $2.56
- 52 Week High
- NVNI $12.19
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- NVNI 58.39
- GNTA 34.44
- Support Level
- NVNI $0.52
- GNTA $2.56
- Resistance Level
- NVNI $0.57
- GNTA $3.69
- Average True Range (ATR)
- NVNI 0.04
- GNTA 0.32
- MACD
- NVNI -0.00
- GNTA -0.07
- Stochastic Oscillator
- NVNI 80.33
- GNTA 20.10
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.